Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Gestational DiabetesHyperglycemia
Interventions
DEVICE

Continuous glucose monitor

CGMs will be worn for a maximum of 10 days at 6-8 weeks postpartum.

DIAGNOSTIC_TEST

Oral Glucose Tolerance Test

At 10-12 weeks postpartum, participants will complete an oral glucose tolerance test, which involves drinking a glucose substance and having glucose levels measured a maximum of 3 times.

DIAGNOSTIC_TEST

Hemoglobin A1c

At 11-14 months postpartum, participants will be asked to have their blood drawn to check their hemoglobin A1c to look for signs of developed insulin resistance

Trial Locations (1)

43210

RECRUITING

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER